<< Back To HomeAntibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
Printable Copy |
|
Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
Brandon D, Kimmel M, Kuriyakose SO, Kostanyan L, Mesaros N.
Vaccine. 2018 Oct 8;36(42):6325-6333.. Epub 2018 Sep 7.
https://www.ncbi.nlm.nih.gov/pubmed/30197282